Nurix Therapeutics (NasdaqGM:NRIX) FY Conference September 10, 2025 07:00 AM ET Company ParticipantsArthur Sands - President and CEOConference Call ParticipantsTerence Flynn - Biopharma AnalystTerence FlynnGreat, great. Good morning. Thanks for joining us, everybody. I'm Terence Flynn, Morgan Stanley's U.S. biopharma analyst. I'm very pleased to be kicking off the third day of our conference this morning, hosting Nurix, and we have Arthur Sands, the company's President and CEO. Thanks so much, Arthur. Befor ...